Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Swiss Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Utah
University of Miami
Thomas Jefferson University
Thomas Jefferson University
University of California, Davis
Memorial Sloan Kettering Cancer Center
Academic and Community Cancer Research United
Medical College of Wisconsin
University of Washington
Loyola University
OHSU Knight Cancer Institute
Stanford University
University of Nebraska
University of Pennsylvania
Weill Medical College of Cornell University
Jewish General Hospital
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Hackensack Meridian Health
University of Washington
The First Affiliated Hospital with Nanjing Medical University
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
University of Michigan Rogel Cancer Center
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
University of Pennsylvania
Mayo Clinic
Alliance for Clinical Trials in Oncology
University of Texas Southwestern Medical Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center